A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer
Clinical trial NCT01497873 · COMPLETED
Trial details
- NCT number
- NCT01497873
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2017-12-01
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.